
Sign up to save your podcasts
Or


We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.
By Retina Synthesis4.5
88 ratings
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.

43 Listeners

18 Listeners

97 Listeners

112,321 Listeners

56,692 Listeners

5 Listeners

9,551 Listeners

11 Listeners

47,686 Listeners

50 Listeners

11 Listeners

466 Listeners

19 Listeners

0 Listeners